Abbvie reported $73.47B in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
ALKERMES ALKS:US $ 294.54M 0.63M
Amgen AMGN:US $ 36522M 332M
Astrazeneca AZN:US $ 29528M 1571M
AstraZeneca AZN:LN 29528M 1571M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Chemocentryx CCXI:US $ 23.72M 0.04M
Coherus Biosciences CHRS:US $ 196.04M 224.42M
Eisai 4523:JP Y 94902M 9M
Eli Lilly And LLY:US $ 16813.8M 305M
Endo International Ordinary Shares ENDP:US $ 8065.3M 25.32M
GlaxoSmithKline GSK:LN 22111M 11217M
Horizon Pharma HZNP:US $ 2566.99M 1.75M
Infinity Pharmaceuticals INFI:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
JAZZ PHA JAZZ:US $ 6021M 2.87M
Medtronic MDT:US $ 24114M 1041M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 31031M 244M
Pacira Pharmaceuticals PCRX:US $ 755.65M 167.77M
Perrigo Ordinary Shares PRGO:US $ 4116.9M 601.7M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Revance Therapeutics RVNC:US $ 396.1M 53.64M
Teva Pharmaceutical Industries TEVA:US $ 22082M 835M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
Zoetis ZTS:US $ 6573M 5M